...
Skip to content
Pure Lab Peptides
Analytical Methods

Peptide Purity, Identity and Content: What Each Result Means

The peptide purity vs identity distinction starts with the question being measured. Identity asks what the material is; purity describes composition under a stated method. Content assigns a measured amount to the target material. Keep those answers separate on a COA rather than asking a percentage to stand for all of them.

Read the method and units beside a value. Similar-looking numbers can answer different questions, which matters before a comparison is made.

HPLC purity and LC-MS identity provide complementary evidence

High-performance liquid chromatography separates components under defined conditions. UV detection records a response as material elutes. Comparing the main peak area with the total integrated area gives an area percentage, whose meaning depends on detection, method and integration.

Liquid chromatography-mass spectrometry adds ion information from the separated material. A molecular-mass assignment can support peptide identity. Agreement with a chromatographic purity result still doesn’t supply an unmeasured content value or other property.

Suppose a hypothetical COA reports 99% HPLC purity. That alone doesn’t mean 99% of the total powder mass is peptide, nor identify the dominant peak. Locate the analytical method and supporting identity evidence before interpreting the figure.

Start with the question, then find the measurement

Your question Evidence to look for Do not substitute
Is this the intended peptide? An identification result and the analytical basis for it A purity percentage alone
What does the purity figure include? The reported purity method, calculation basis and relevant qualifications An assumption that the value describes every component in the vial
How much target material was measured? A quantitative assay or content result, with units and reference basis The product’s nominal label amount

Keep the laboratory’s labels in your notes. Record HPLC purity as HPLC purity and milligrams per vial with that unit. When a basis is missing, ask for clarification; relabeling the number won’t resolve it.

Chromatographic purity is not complete vial composition

A chromatographic percentage stays attached to its method and calculation. It doesn’t automatically describe peptide as a fraction of the entire vial mass. The COA interpretation guide keeps that distinction visible alongside measured content, total mass and other components.

Metrology researchers studying an angiotensin I calibrator compared several approaches to assigning purity mass fraction, including mass balance, impurity-corrected amino acid analysis, elemental analysis and quantitative NMR. That is a defined measurement problem, not a synonym for any number labeled purity. See Josephs and colleagues’ study record at NIST.

Before comparing reports, check whether their methods and reporting bases fit the comparison you need. A difference between values doesn’t explain its cause.

Identity needs its own evidence

An identity result should identify the analytical information used to support the assignment. An intact-mass comparison, a sequence investigation and another structural technique can provide different information. McCarthy and colleagues used complementary methods to characterize peptide reference standards and noted that certain isobaric or chiral features need additional techniques. Their study explains the context; it does not certify an unrelated commercial lot.

Check the documentation for the specific material. A technique described in a publication or elsewhere on a website isn’t evidence that the laboratory performed it on this sample.

Content is a quantitative assignment

In a multi-laboratory oxytocin study, investigators compared HPLC assay, quantitative NMR and amino acid analysis for quantitation. The work illustrates why the reference basis and method matter when assigning peptide content. The findings concern that study and material, not a universal ranking of testing methods. Read the NIST publication record.

Is the listed amount a label claim or a measured result? Record both when the report supplies both. Neither should silently replace the other, and a mass-based result shouldn’t become a biological activity claim.

Peptide-related impurities and other sample components

A deletion variant, oxidized form or unrelated residual component raises a different analytical question. Closely related molecules can be difficult to separate, and an impurity may coelute with the main peak under a particular chromatographic method.

Water, counterions and residual solvents need their own reporting context. A clean UV trace doesn’t establish their absence. A general manufacturing description doesn’t establish their amounts either.

Does high purity mean the material is suitable for any use?

No. A high purity figure does not establish sterility, endotoxin status, biological activity or suitability for human use. It also does not prove that the material remained unchanged after testing. Those are separate questions with their own evidence requirements.

Start an acceptance decision with the research task and required specification. No single percentage makes every peptide suitable for every experiment. Keep identity, purity, content and the other required findings in the decision record.

Make a comparison you can explain later

A short review note can identify the material, lot, report number, identity evidence, purity method and measured content. Mark unanswered fields as unanswered. That gives the next reviewer more to work with than a single quality score.

The How to Read a Peptide COA puts these measurements into the report-reading workflow. Retain the original laboratory report so each value and follow-up question can be checked against what it actually contains.